Clinical trials are conducted within established scientific and ethical frameworks designed to support consistent and well-governed research.
Data and Safety Monitoring Boards (DSMBs) are one component of this framework. These independent groups review accumulating data during a trial and provide recommendations to support appropriate study conduct.
A recent article from The Task Force for Global Health highlights the importance of these roles and the need to strengthen global capacity.
Read the article: https://www.taskforce.org/before-the-first-dose-building-trust-before-disease-strikes/
A SPEAC-led approach to DSMB training
The Safety Platform for Emergency vACcines, SPEAC, leads a dedicated DSMB training program designed to prepare experts for these responsibilities.
The program combines technical instruction with applied learning, including case-based scenarios that reflect real-world trial contexts. It focuses on:
- Structured approaches to reviewing clinical trial data
- Consistency in interpretation and recommendation processes
- Independence and conflict-of-interest management
- Alignment with established governance and regulatory frameworks
SPEAC operates as part of the Brighton Collaboration, and this training aligns with broader efforts to support standardized, globally relevant approaches to vaccine safety and clinical research.
Supporting consistent oversight
DSMBs provide independent input within clinical trials. Strengthening training and access to these roles helps support consistent, well-informed decision-making across studies and regions.
A routine but essential function
Although not always visible outside research settings, DSMBs are a standard component of clinical trial infrastructure.
Efforts to expand training contribute to maintaining high-quality oversight and reinforcing established approaches to clinical research governance.
SPEAC is fully funded by CEPI, the Coalition for Epidemic Preparedness Innovations.
